Medicare Prescription Drug Price Negotiation Act of 2019
Bill journey · stage 1 of 5
Just introduced
What it doesSummary introduced in house (Jan 8, 2019)
Medicare Prescription Drug Price Negotiation Act of 2019
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
What just happenedSep 25, 2019
Subcommittee Hearings Held.
Who’s behind it
- Introduced in HouseJan 8, 2019
- Sep 25, 2019Committee
Subcommittee Hearings Held.
Health Subcommittee - Jan 25, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 8, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jan 8, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jan 8, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 8, 2019IntroReferralIntro-H
Introduced in House
- Jan 8, 2019IntroReferral1000
Introduced in House